The status of ongoing trials for mild cognitive impairment

Author： Sramek J.J.   Veroff A.E.   Cutler N.R.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.4, 2001-04, pp. : 741-752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer’s disease – Challenges and Perspectives

By  

Current Pharmaceutical Design, Vol. 20, Iss. 18, 2014-06 ,pp. : 3083-3092

Bentham Science Publishers

Access to resources Recommend Favorite

Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 520-528

Bentham Science Publishers

Access to resources Recommend Favorite

Improved memory with AL 108 in mild cognitive impairment

By  

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Ongoing Trials

By  

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 322-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identifying Amnestic Mild Cognitive Impairment in Primary Care: A Feasibility Study

By Doody Rachelle S.  

Clinical Drug Investigation, Vol. 31, Iss. 7, 2011-07 ,pp. : 483-491

Adis International

Access to resources Recommend Favorite